T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 14.7 %

Shares of NASDAQ TTOO opened at $0.13 on Tuesday. T2 Biosystems has a one year low of $0.06 and a one year high of $6.80. The business’s fifty day moving average price is $0.18 and its 200-day moving average price is $0.81.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.